Related Experiment Video
Updated: Jun 25, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation
H Barroca1, S Castedo, J Vieira
1Laboratório de Anatomia Patológica, Al. Hernani Monteiro 4200-451, Hospital de S. João, Porto, Portugal. hbarroca@gmail.com
Abstract:
Renal cell carcinoma (RCC) is a rare tumor in the pediatric population. Recently, a phenotypically and genetically distinct kidney carcinoma, mainly prevalent in children and associated with an Xp11.2 translocation or TFE3 gene fusion, has been described. It has been advanced that in this subtype of RCC, there is an accumulation of cyclin D1, cyclin D3, and p21 ((wafl/cip1)). The aim of the present study was to figure out in two pediatric RCC recently diagnosed in our department (one clear cell-type RCC and one TFE3-positive RCC) whether those features are indeed specific of the latter tumor or occur in pediatric RCC irrespective of the tumor type. The following immunostains were performed in both cases: Ki67, p16(ink4a), p21 ((wafl/cip1)), p27(kip1), p53, p63, mdm2, cyclin D1, cyclin D3, TFE3, CD10, vimentin, E-cadherin, and RCC-antigen. We observed in the TFE3-positive carcinoma an intense immunoreaction for p21 ((wafl/cip1)), cyclin D1, and cyclin D3, without expression for p53, p16, p27(kip1), and mdm2, whereas the immunoexpression profile observed in the classic RCC was similar to that of clear cell, adult-type RCC. Our study confirms that TFE3-positive RCC exhibits a deregulation of the cell cycle apparently unrelated to the young age of the patients.
Insights
Pediatric TFE3-positive renal cell carcinoma (RCC) shows cell cycle deregulation, unlike typical childhood RCC. This finding highlights distinct molecular pathways in rare pediatric kidney cancers.
Area of Science:
- Oncology
- Pediatric Pathology
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) is uncommon in children.
- A distinct pediatric subtype of RCC is associated with Xp11.2 translocations or TFE3 gene fusions.
- This TFE3-positive RCC subtype is hypothesized to involve cyclin D1, cyclin D3, and p21 accumulation.
Observation:
- This study investigated two pediatric RCC cases: one clear cell-type and one TFE3-positive.
- Immunohistochemical analysis included markers for cell proliferation (Ki67), cell cycle regulators (p16, p21, p27), tumor suppressors (p53, mdm2), and specific markers (TFE3, CD10, vimentin, E-cadherin, RCC-antigen).
Findings:
- TFE3-positive RCC displayed intense p21, cyclin D1, and cyclin D3 immunoreactivity.
- The TFE3-positive tumor lacked expression of p53, p16, p27(kip1), and mdm2.
- The clear cell RCC showed an immunoexpression profile similar to adult clear cell RCC.
Implications:
- The cell cycle deregulation observed in TFE3-positive RCC appears independent of patient age.
- These findings suggest unique molecular mechanisms driving TFE3-positive pediatric kidney cancer.
- Distinguishing TFE3-positive RCC from other pediatric renal tumors is crucial for understanding pathogenesis and guiding treatment.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Inhibition of Cdk Activity
